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42 patients received cyclosporine. Our current one-year graft 
survival in all recipients of LRD allografts is 95%, cyc1osporine 
being used in all except HLA-identical recipients. 
Twenty-one patients (50%) currently have functioning allo-
grafts 1-14 ye posttransplantation (mean: 5 years). Allograft 
failure occurred eight patients within one year following 
transplantation. In 0 of these patients, arterial occlusion 
resulted in graft loss a 1 and 3 days, respectively. In the 
remaining six patients, rej . n was responsible for graft loss. 
In three of these six patients, im osuppreasion was less than 
optimum because of concurrent se . A fourth patient was 
noncompliant with her immunosup ssive medications. 
Chronic rejection led to graft loss at 20 mo s in one patient 
and at 6, 7, and 14 years posttransplantation . 
respectively. 
In summary, no adverse affect upon patient s . al was 
noted due to the presence of MRA. MRA, however, adv Iy 
affected graft survival in two cases. One allograft was lost 
the early postoperative period due to infarction following rep . 
of a completely transected superior polar vessel. It mus 
stressed that this complication has not occurred sin 976, 
and therefore, as more experience was gained, inju to these 
small vessels has been avoided. In the second pa . nt, ligation 
of a superior polar vessel with resultant hype sion may have 
contributed to allograft loss 20 months fo wing transplanta-
tion. 
The presence of MRA and the a tional time required for 
arterial reconstruction contribu to postoperative ATN in 
only one patient, who required enous patch angioplasty prior 
to arterial reconstruction. I our recent experience, renovas-
cular hypertension seeon to RAS occurred in 39 of 547 
renal allograft recipien 7.1 %) (2). In the present series, RAS 
was present in 5% patients. In all cases RAS occurred 
proximal to the . al reconstruction. 
The most freque urologic complication in the present series 
was distal ureteral fistula (in three patients). Interference with 
blood flow to the ureter may have occurred during dissection 
of the inferior polar artery. The presence of multiple renal 
arteries has previously been recognized as contributing to the 
formation of ureteral fistulae (3). Concurrent rejection in one 
patient may also have further affected blood flow to the ureter. 
No allografts were lost secondary to urologic complications. 
In conclusion, the present study demons tes that the use 
of donors with MRA is associated wit creased risk to the 
allograft. Nonetheless, satisfactol'Y. tient and graft survival 
was achieved. Exclusion of don based upon the presence of 
MRA would deny a large n r of patients the advantages of 
an LRD renal allo in our series, and place further 
supply of cadaveric renal allografts. 
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PORTAL VEIN THROMBOEMBOLISM OF LIVER ALWGRAFrS FROM SPLENECTOMIZED DONORS! 
Since first reported by Delatour (1) in 1895, thrombosis of 
the splenoportal venous system has been known as a serious 
complication of splenectomy. This complication primarily af-
fects patients with congestive splenomegaly and myeloprolif-
erative disorders (2, 3), and is supposedly rare after splenec-
tomy for trauma or incidental injury during laparotomy (4, 5). 
We describe two patienta who underwent splenectomy for 
trauma, in whom thromboembolism of the portal vein was 
identifIed later in the livers harvested for liver transplantation. 
Case 1. A 13-year-old boy was involved in a traffic accident 
on July 1, 1987, and suffered from multiple trauma. The patient 
underwent splenectomy, in addition to other procedures. Be-
cause of irreversible head injury, the patient became a multiple 
organ donor, and the heart, Over and left kidney, were procured. 
The laboratory data before the organ donation were: SGOT 
100 lUlL, SGPT 46 lUlL, total bilirubin 1.7 mg/dl, prothrom-
bin time 13.7 sec, partial thromboplastin time 24.S sec, leuko-
I Tbia work was BUppOrted by Reeean:h Grants from the Veterans 
Administration and Project Grant No. AM 29961 from the National 
Institute of Health, Bethesda, Maryland. 
cyte count 1OKRu1~/mmPI hematocrit level 42.4%. The platelet 
count was not measured. At the time of organ procurement, the 
liver appeared grossly normal and soft on palpation, and the 
intestine showed no evidence of venous congestion or edema. 
A small amount of serosanguinous fluid was seen in the peri-
toneal cavity. In view of the extensive retroperitoneal hema-
toma. a rapid flush technique (6) was used: Briefly, the portal 
cannula was inserted into the portal vein through the inferior 
mesenteric vein; following croea-clamp of the supraceliac aorta, 
the intraabdominal organs were flushed with cold solution from 
the portal as weD as terminal aortic cannulae. The allograft 
hepatectomy was uneventful with immediate blanching and 
fast cooling of the liver. The liver was then transplanted into a 
recipient with Laennec'. cirrhoeia. When the donor portal vein 
was transected prior to ita anastomosis with the recipient portal 
vein, a fresh clot was found at the cut margin. The clot, which 
was cylindrical and measured 6.2X0.4xO.2 cm, was removed 
and a Fogarty catheter was passed into the allograft portal 
vein, which showed DO evidence of residual thromboemboli. 
Following the portal vein anastomosis, the liver allograft was 
revascularized, and excellent reperfusion was observed. The 
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liver allograft functioned well and the recipient's postoperative 
recovery was uneventful except for an episode of rejection. An 
ultrasonograph performed on the eleventh postoperative day 
showed no evidence of portal vein thrombi. The recipient was 
discharged 48 days postoperatively with good allograft function. 
Case 2. A 19-year-old male patient was involved in a motor-
cycle accident on December 27,1987, in which he suffered from 
closed-head injury and blunt abdominal trauma. The patient 
underwent splenectomy for lacerated spleen. Because of ine-
versible brain damage, he became a multiple organ donor. The 
laboratory data prior to the organ donation were: SOOT 73 IU / 
L, SGPT 46 IU fL, total bilirubin 0.7 mg/dl, prothrombin time 
12.8 sec, partial thromboplastin time 26.9 sec, leukocyte count 
15.8xIQ3/mm3 , hematocrit level 33.9%, and platelet count 
146xIQ3 /mm3• The liver and intestines appeared normal during 
organ recovery. The pancreas felt firm, but a biopsy of the 
pancreas showed no evidence of pancreatitis. No ascites was 
present. The portal cannula was inserted through the splenic 
vein after caudad mobilization of the pancreas. At the time of 
cannulation of the splenic vein, no clot was encountered. The 
supraceliac abdominal aorta was cross-clamped, and the in-
traabdominal organs were flushed with cold solution from the 
portal and terminal aortic cannulae. The liver blanched and 
cooled down fast, and hepatectomy was performed without 
difficulty. When the graft was brought back and a redundant 
portion of the donor portal vein was excised immediately before 
portal vein anastomosis, a semiorganized clot measuring 
2.0XO.8xO.8 cm was found lying loose in the donor portal vein. 
The clot was removed and the portal vein anastomosis was 
completed. The allograft perfused and functioned well. A Dop-
pler ultrasonograph performed on the eighth postoperative day 
showed patent portal vein without any evidence of portal vein 
thromboemboli. The recipient was discharged 28 days postop-
eratively with good graft function. 
Both donors were victims of multiple trauma in traffic acci-
denta, for whom splenectomy was performed for blunt abdom-
inal trauma. At the time of multiple organ donation, the liver 
and intestines showed no evidence of pathology, and liver 
allografts were harvested without technical difficulty. The in-
tervale between splenectomy and multiple organ donation was 
1 and 4 days, respectively. Fresh or semi-organized clota were 
identified lying loose in the portal vein of the liver allografts 
immediately before the portal vein anastomosis in the recipi-
enta. 
It is unlikely that the donors had portal or superior mesen-
teric vein thrombosis before multiple organ donation, since the 
liver and intestines looked grossly normal, no bloody ascites or 
melena was observed, and posttransplant liver functions in the 
recipienta of the livers were excellent without ischemic damage. 
Also, formation of a thrombus in the portal or superior mes-
enteric vein during liver harvesting in case 1 is unlikely, since 
the portal cannula was inserted immediately before cross-
clamping of the aorta, without interfering with the superior 
mesenteric venous flow, and since 3 mi/kg of heparin was 
administered immediately after the portal cannulation. 
Salter et al. (4) reported splenic vein thrombosis after sple-
nectomy in 3 out of 7 patienta (42.9%) on autopsy, and Broe et 
al. (3) described 2 patienta in whom postmortem examination 
~ the extension of thrombus from the splenic vein 
remnant to the portal vein. Since the splenic vein after the 
splenectomy becomes a cul-de-sac with very low flow, it is not 
surprising for a thrombus to form in this remnant structure 
(3). Allograft hepatectomy is associated with significant ma-
nipulation of the splenoportal venous system. The size of the 
cylindrical thromboemboli in the allograft portal vein, 
6.2xOAxO.2 cm in case 1 and 2.0xO.8xO.8 cm in case 2, seems 
to correlate with the size of the residual splenic vein in case 1, 
and the size of the splenic vein remnant proximal to the distal 
splenic ligature placed for cannulation of the portal cannula 
through the splenic vein in case 2. Although not confirmatory, 
it is suggested that the thromboemboli in our donors were 
formed in the residual splenic vein, and dislodged into the 
portal vein during liver allograft harvesting. 
Although portal vein thrombosis has been rare after liver 
transplantation in our experience (7), it can occur, and when 
it does, there is usually no good explanation for a thrombosis 
that apparently began in the liver allograft and extended doWD-
ward Emboli already present in the graft at the time of organ 
procurement could be responsible. 
When liver allografts are harvested from splenectomized 
donors, manipulation of the remnant splenic vein or the pan-
creas should be minimized. and the portal vein of the graft 
should be examined immediately after allograft hepatectomy in 
the donor hospital, in order to avoid a disastrous portal vein 
thrombosis in the recipient. 
KATSUHIKO YANAGA 
ANDREI STIEBER 
BABURAO KONERU 
LUIS A. MIELES 
ANDREAS G. TZAKIS 
THOMAS E. STARZL 2 
Department of Surgery 
University Health Center of Pittsburgh 
University of Pittsburgh 
Pittsburgh, Pennsylvania 15213 
S Address reprint requesta to Thomas E. Starzl, M.D., Ph.D., De-
partment of Surgery. University of Pittsburgh School of Medicine, Falk 
Clinic. West, 3601 Fifth Avenue, Pittsburgh, Pennsy:,ania 15213. 
REFERENCES 
1. Delatour HB. Thrombosis of mesenteric vein as a cause of death 
after splenectomy. Ann Surg 1895; 21: 24. 
2. Davis HH, Sharpe JC. Splenic vein thrombosis following splenec-
tomy. Surg Gynecol Obstet 1981; 67: 678. 
3. Broe PJ, Conley CL. Cameron JL. Thrombosis of the portal vein 
following splenectomy for myeloid metaplasia. Surg Gyneco\ 
Obstet 1981; 152: 488. . 
o4. Salter PP. Sherlock EC. Splenectomy, thrombocytosis and venous 
thrombosis. Am Sure 1957; 23: 5-49. 
5. Boxer MA, Braun J, Ellman L. thromboembolic risk of poataple-
nectomy thrombocytosis. Arch Surg 1978; 113: 808. 
6. Sta.rzl TE, Miller C, BJOZniek B, Makowka L. An improved tech-
nique for multiple organ harveeting. Surg Gynecol Obstat 1987; 
166: 3-43. 
7. Lerut J, Tzakia AG. Bron K, et al. Complications of venous 
reconstruction in human orthotopic liver transplantation. Ann 
SUJ'I1987; 205: 40'. 
Received 7 June 1988. 
Accepted 30 June 1988. 
